| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 75.642 | 66.296 | 69.273 | 15.727 | - | - | - | - | - | - |
| Total Income - EUR | 75.646 | 66.296 | 69.273 | 15.727 | - | - | - | - | - | - |
| Total Expenses - EUR | 86.302 | 70.676 | 73.781 | 24.329 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -10.656 | -4.380 | -4.509 | -8.602 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -12.926 | -5.561 | -5.202 | -8.759 | - | - | - | - | - | - |
| Employees | 2 | 3 | 3 | 1 | - | - | - | - | - | - |
Check the financial reports for the company - Zhongou Improdex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 102.489 | 120.897 | 118.851 | 116.670 | - | - | - | - | - | - |
| Current Assets | 61.081 | 35.113 | 29.342 | 32.505 | - | - | - | - | - | - |
| Inventories | 32.723 | 15.225 | 10.135 | 10.372 | - | - | - | - | - | - |
| Receivables | 18.101 | 19.851 | 19.113 | 21.811 | - | - | - | - | - | - |
| Cash | 10.257 | 37 | 95 | 321 | - | - | - | - | - | - |
| Shareholders Funds | 113.385 | 106.668 | 98.697 | 88.127 | - | - | - | - | - | - |
| Social Capital | 81.440 | 80.609 | 79.245 | 77.791 | - | - | - | - | - | - |
| Debts | 50.185 | 49.343 | 49.496 | 61.049 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4642 - 4642" | |||||||||
| CAEN Financial Year |
4642
|
|||||||||
Comments - Zhongou Improdex Srl